Dopamine treatment effects in Parkinson's disease
Part of Brain & nervous system clinical trials.
This study looks at how the stomach breaks down dopamine medication in people with Parkinson's disease. It uses stomach tissue samples already collected during a routine endoscopy to understand why some people may not respond well to treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Parkinson's disease
- You are currently taking dopamine replacement therapy
- You have had a stomach biopsy taken during a previous endoscopy
- You have not been diagnosed with Parkinson's disease (you must have it)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a new pump treatment (foslevodopa/foscarbidopa) for people with advanced Parkinson's who are having motor fluctuations. It aims to see if it improves quality of life when started earlier in the advanced stage.
This study looks at how digestive (gut) problems happen in people with Parkinson’s and whether there are related changes in the nerve tissue in the digestive tract. It may help researchers better understand the cause of these symptoms and find new ways to monitor or treat them.
This trial tests if taking daily amino acid supplements helps people with Parkinson's disease. You need to be on stable Parkinson's medication for at least 3 months.
This study explores how bacteria in the small intestine affect how well the Parkinson's medication L-dopa works. It involves swallowing a special capsule to collect gut samples.
This study uses a special test to look at dopamine levels in the brain of people with Parkinson's disease. It may help doctors understand the disease better and could lead to better treatments.
This study checks whether measuring levodopa (a Parkinson medicine) in real time can help better understand Parkinson medication effects. You may be asked to wear/perform study monitoring while taking your usual carbidopa/levodopa tablets.
Hear when a new Parkinson’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.